Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy

doi:10.4291/wjgp.v15.i4.93606

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3500)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

HTML

2405

Figures (1-9)

212

Tables (1-2)

210

Sum=2886

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

141

Download

192

Sum=333

Publishing Process of This Article

Item

Count

Browse

Download

Sum=132

Aug 22, 2024 (publication date) through Mar 2, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pathophysiol. Aug 22, 2024; 15(4): 93606
Published online Aug 22, 2024. doi: 10.4291/wjgp.v15.i4.93606

Full Size Figure Download Figure

Figure 2 The key modulators of carbohydrate and fat metabolism. Orange arrow indicates negative relationship and blue arrow indicates positive relationship[254]. FA: Fatty acid; GLP1: Glucagon like peptide 1; GIP1: Gastric inhibitory peptide 1; FXR: Farnesoid X receptor; PPAR: Peroxisome proliferator-activated receptor; GLUT: Glucose transporters; LPL: Lipoprotein lipase; ATGL: Adipose triglycerides lipase; HSL: Hormone sensitive lipase. Citation: Habib S. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping. World J Gastrointest Pathophysiol 2024; 15: 92791. Copyright © The Baishideng Publishing Group 2024. Published by Baishideng Publishing Group.

Citation: Habib S. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy. World J Gastrointest Pathophysiol 2024; 15(4): 93606
URL: https://www.wjgnet.com/2150-5330/full/v15/i4/93606.htm
DOI: https://dx.doi.org/10.4291/wjgp.v15.i4.93606